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Summary Introduction
A number of genes have been found to be mutated inThe identiﬁcation of genes responsible for the rare cases of
leukemia, largely through the cloning of somatic translo-familial leukemia may afford insight into the mechanism
cation breakpoints and the screening of known tumorunderlying the more common sporadic occurrences. Here
suppressor genes, oncogenes, and other genes with cellu-we test a single family with 11 relevant meioses transmitting
lar regulatory function (Sachs 1996). However, theautosomal dominant acute myelogenous leukemia (AML)
pathogenic mutations that initiate the multistep evolu-and myelodysplasia for linkage to three potential candidate
tion of leukemia have been more difﬁcult to elucidateloci. In a different family with inherited AML, linkage to
(Fialkow et al. 1991; Busque and Gilliland 1993). Rarechromosome 21q22.1-22.2 was recently reported; we ex-
autosomal dominant cancer families provide an oppor-clude linkage to 21q22.1-22.2, demonstrating that familial
tunity to study genes involved in the earliest phases ofAML is a heterogeneous disease. After reviewing familial
malignancy (Knudson 1993).leukemia and observing anticipation in the form of a declin-
Familial leukemia is exceptionally rare; we are awareing age of onset with each generation, we had proposed
of only three extant pedigrees that have been adequately9p21-22 and 16q22 as additional candidate loci. Whereas
sampled (Ho et al. 1996; Horwitz et al. 1996b; Olopadelinkage to 9p21-22 can be excluded, the ﬁnding of a maxi-
et al. 1996). The difﬁculty of ascertaining large leukemiamum two-point LOD score of 2.82 with the microsatellite
families with multiple available affected members limitsmarkerD16S522 at a recombination fractionuÅ 0 provides
the power of a genomewide survey for linkage andevidence supporting linkage to 16q22. Haplotype analysis
makes evaluation of candidate loci a more feasible ap-reveals a 23.5-cM (17.9-Mb) commonly inherited region
proach. In previous reviews of the clinical features ofamong all affected family members extending from
familial leukemia (Horwitz et al. 1996a; Horwitz 1997),D16S451 toD16S289. In order to extractmaximum linkage
we observed anticipation, in the form of a declining ageinformation with missing individuals, incomplete informa-
at onset with each passing generation, and proposedtiveness with individual markers in this interval, and possible
potential candidate regions: In a family inheriting au-deviance from strict autosomal dominant inheritance, we
tosomal dominant myelodysplasia and acute myeloge-performed nonparametric linkage analysis (NPL) and found
nous leukemia (AML) of multiple subtypes, which servesa maximum NPL statistic corresponding to a P-value of
as the subject of the current study, we found that two.00098, close to the maximum conditional probability of
affected individuals shared a constitutional cytogeneticlinkage expected for a pedigree with this structure. Muta-
euchromatic banding variation at chromosome 9p21-22tional analysis in this region speciﬁcally excludes expansion
(Horwitz et al. 1996b), suggesting potential linkage toof the AT-rich minisatellite repeat FRA16B fragile site and
this region. Evidence supporting a chromosome 21 locusthe CAG trinucleotide repeat in the E2F-4 transcription fac-
includes the ﬁnding of linkage for a platelet disordertor. The ‘‘repeat expansion detection’’ method, capable of
and propensity to develop AML to 21q22.1-22.2 in onedetecting dynamic mutation associated with anticipation,
family (Ho et al. 1996), an increased incidence of leuke-
more generally excludes large CAG repeat expansion as a mia in Down syndrome (Epstein 1995), and frequent
cause of leukemia in this family. somatic translocation in leukemia involving the CBFA
gene on 21q22.3. We proposed 16q22 as a potential
familial leukemia candidate region (Horwitz et al.
1996a; Horwitz 1997), in part because of a report of aReceived May 6, 1997; accepted for publication July 23, 1997.
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The family that we have described (Horwitz et al. fected, at-risk individuals, including obligate heterozy-
gotes II-1, II-5, and III-5, consented to clinical and bone1996b) may be particularly valuable in the study of leu-
kemia genesis because affected family members have de- marrow examination; therefore, the sample available for
linkage testing, for which clinical phenotype was avail-veloped myelodysplasia or AML of differing subtypes,
indicating that the responsible gene operates at a primi- able, consisted solely of affected individuals.
tive and signal step in myeloid differentiation. In the
Linkage Analysiscurrent article, we evaluate linkage of disease in this
family to these proposed candidate loci and report provi- Since all individuals at risk for leukemia included in
the linkage analysis were either affected or obligate het-sional evidence for assignment of the disease to chromo-
some 16q21-23.2. In addition, we conduct preliminary erozygotes, and the overall incidence of AML (Ho et al.
1996) is low (.0001), it was possible to use an autosomalmutational analysis of repetitive sequence elements in
this region, because familial leukemia displays anticipa- dominant model of inheritance that is essentially inde-
pendent of penetrance. This avoids the consideration oftion (Horwitz et al. 1996a). The only known mechanism
of anticipation results from the instability of repeat se- anticipation and age-dependent penetrance. The data
were initially examined under this single conservativequences (La Spada et al. 1994; Sutherland and Richards
1995), although we have also proposed a model of antic- model with gene frequency set to .0001, ﬁxed prior to
obtaining genotypes.ipation in familial cancer based on polygenic inheritance
of multiple de novo mutations secondary to a loss of a Genotype information was generated with PCR am-
pliﬁcation of microsatellite repeat polymorphisms. PCRmajor gene regulating DNA replication ﬁdelity (Horwitz
1997). was employed with end-labeled primers or in the pres-
ence of [a32P]dCTP, using protocols published in the
Genome Database (Fasman et al. 1996), and the prod-Subjects and Methods
ucts were analyzed by 6% denaturing PAGE and autora-
Clinical Description and DNA Sources diography.
Two-point LOD scores were calculated using theRelevant individuals in the pedigree are shown in ﬁg-
ure 1. Diagnostic criteria were previously established, MLINK subroutine of the LINKAGE software package,
version 5.1 (Lathrop et al. 1984), and maximum likeli-and a full clinical description has been reported (Hor-
witz et al. 1996b). All affected individuals had frank hood estimate of u was performed with the ILINK sub-
routine. Nonparametric linkage analysis was performedhematopoietic maturation defects documented by bone
marrow examination interpreted by at least one hemato- with GENEHUNTER software, version 1.1 (Kruglyak
et al. 1996). Allele frequencies for markers were takenpathologist unaware of the family history. The proband
is individual IV-1, who hadM7megakaryoblastic AML. from the Genome Database, except for the chromosome
21 marker UT7582 and D16S398, for which informa-Individuals II-3 and II-1 had M2 AML. Patients III-3
and III-4 had myelodysplastic syndrome terminating in tion is not published. Allele frequencies for UT7582
were determined by genotyping 32 chromosomes fromAML. Because of limited clinical information, it was not
possible to determine leukemia subtype on patient II-3. unrelated individuals in CEPH families (M. F. Leppert,
unpublished data). Allele frequencies for D16S398 wereIndividual IV-3 had myelodysplasia with monosomy of
chromosome 7 in bone marrow cells. Patients II-4 and derived using family-based allele frequency estimation
(Boehnke 1991); LOD scores were determined usingIV-2 had bone marrow abnormalities consistent with
incipient myelodysplasia; in addition, a rare opportunis- ILINK to estimate iteratively allele frequencies jointly
with maximum likelihood estimation of u (Terwilligertic mycobacterial infection contributed to the death of
patient II-4. and Ott 1994, pp. 185–87), starting with the allele fre-
quencies observed in the three genotyped founders, II-DNA was obtained from various preparations as fol-
lows: buffy coat from peripheral blood from individuals 6, III-6, and IV-3. The LOD scores for the other chromo-
some 16 markers were separately evaluated using thisIV-1 and IV-2; Epstein-Barr virus–transformed poly-
clonal lymphoblastoid cell lines derived from peripheral method, to assess the inﬂuence of allele frequencies in
this family in which genotypes of several founders areblood from individuals II-1, II-5, II-6, III-1, III-5, III-6,
and IV-3; parafﬁn blocks of autopsy-derived liver on absent.
patient II-3, biopsied lymph nodes on patient II-4, bone
Mutational Analysismarrow biopsy on patient III-2, skeletal muscle on pa-
tient III-3; and air-dried microscope slides of bone mar- PCR quantiﬁcation of the AT-rich FRA16B minisatel-
lite repeat (Yu et al. 1997) was performed in 16.5 mMrow aspirate on patient III-4. Archival DNA was ex-
tracted by the QIAGENQIAamp tissue kit and was used (NH4)2SO4, 4.5 mMMgCl2, 67 mM Tris-HCl (pH 8.8),
0.65 mM EDTA, 0.17 mg/ml BSA, 10% (v/v) dimethylaccording to the manufacturer’s instructions. Archival
material was not used for linkage analysis on chromo- sulfoxide (DMSO), 1.42 mM b-mercaptoethanol, 1.5
mM each of the four dNTPs, 5 mCi [a32P]dATP, 50 ngsomes 9p21-22 and 21q22.1-22.2. No apparently unaf-
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Figure 1 Pedigree and haplotype analysis for chromosome 16q21-23.2. Solid symbols denote affected individuals. The common haplotype
is denoted in black. Dashes (-) indicate not tested or a failure to detect a PCR ampliﬁcation product. Inferred genotypes are given in parentheses.
(Inferred genotypes were not used in the linkage analysis.)
of DNA sample, 37.5 ng of each primer (5-TGTAAA- step of 94C for 5 min; and products were analyzed by
7% denaturing PAGE with autoradiography.ACGACGGCCCAGTGTACTATACTATACTATATT-
ATACAG-3 and 5-CAGGAAACAGCTATGACCGTA-
TTATATATTATCTAATTATATCTTATATATTGA- Results
ATATTAC-3), and 2.5 U Taq polymerase for 10 cycles
Exclusion of Linkage to 9p21-22 and 21q22.1-22.2of 88C at 30 s, 45C at 30 s, and 58C at 3 min and
20 cycles of 88C at 30 s, 50C at 30 s, and 58C at 3 In the initial clinical evaluation of this family (Horwitz
et al. 1996b), we observed a constitutional euchromaticmin. Products were analyzed by denaturing PAGE and
autoradiography. banding variation of chromosome 9p21-22 in patient
IV-3 and in a grandson of patient II-3 (implying its pres-PCR ampliﬁcation of the E2F-4 CAG repeat was per-
formed as described by Ginsberg et al. (1994). PCR ence in patient II-3, who died before the era of routine
cytogenetic testing in leukemia). One candidate gene inampliﬁcation of the AF9 CAG repeat was performed as
described by Walker et al. (1994). this region isAF9,which is the frequent site of reciprocal
translocation with the MLL gene on chromosome 11 inRepeat expansion detection (RED) analysis was per-
formed as described by Bleyl et al. (1995) with the fol- recurrent t(9;11)(p22;q23) associated with AML (Na-
kamura et al. 1993). Furthermore, AF9 has a polymor-lowing modiﬁcations: the (CTG)15 oligonucleotide was
puriﬁed by 19% nondenaturing PAGE after [g32P]ATP phic polyserine-encoding CAG repeat (Walker et al.
1994) that is of interest in view of the observation ofphosphorylation; 396 cycles of 94C for 10 s and 80C
for 30 s were performed after an initial denaturation anticipation in familial leukemia (Horwitz et al. 1996a).
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Linkage analysis with the markers D9S126 on 9p21 and by two affected second cousins (IV-1 and IV-3)
prompted further investigation of linkage to this region.IFNA on 9p22 (table 1) effectively excludes linkage to
this region. In addition, karyotypes of individuals III-2 Results of linkage analysis to multiple ﬂanking mark-
and IV-1 failed to reveal the cytogenetic variation, and ers in 16q21-23.2 are shown in table 2. A maximum
PCR ampliﬁcation of the CAG repeat in AF9 demon- two-point LOD score of 2.82 occurs with the marker
strated that all individuals in this family were homozy- D16S522 at uÅ 0. All affected individuals share a haplo-
gous for the most common allele of 42 repeats (not type without recombination extending 23.5 cM (or 17.9
shown). Mb, as determined from the chromosome 16 physical
map [Doggett et al. 1995]) from D16S451 to D16S289In a large family inheriting platelet granule defects
and a predisposition to AML, linkage to a 15.2-cM in- (ﬁg. 1).
terval on chromosome 21q22.1-22.2 has been deter- Linkage analysis in this family is limited by missing
mined (Ho et al. 1996). That family differs from the individuals and is therefore a function of the estimated
subject family here by the presence in the prior family population allele frequencies. To gauge the effect of this
of platelet granule and aggregation defects, constitutive potential bias, we also calculated LOD scores with a
thrombocytopenia, an evident risk for solid tumors, and family-based approach to estimate allele frequency
an apparently lower penetrance of AML that may occur (Boehnke 1991). Since the allele segregating with leuke-
after solid tumor treatment with chemotherapy (Dow- mia for several of the markers is not observed in the
ton et al. 1985). However, this locus is an obvious candi- unrelated founders, we conclude the reported LOD
date for other leukemia families, especially in light of scores to be conservative. For example, when this ap-
the fact that it is the site for recurrent t(8;21)(q22;q22) proach is used for D16S522 or D16S265, Zmax inﬂates
of the CBFA gene in many cases of sporadic AML and to Ç3.00.
the association of Down syndrome with leukemia (Ep- Linkage analysis in this family is further limited by a
stein 1988). Two-point linkage analysis of six markers lack of informativeness for all markers with each meiosis
spanning an Ç12.4-cM interval excludes linkage of dis- and the potential for model misspeciﬁcation due to pos-
ease in our family to 21q22.1-22.2 (table 1). sible complex inheritance (Horwitz 1997). In order to
extract maximum linkage information under these re-
strictions, we evaluated the genotype data utilizing non-Evidence Supporting Linkage to 16q21-23.2
parametric linkage analysis (NPL; Kruglyak et al. 1996)It has been proposed that inherited fragile sites might
as shown in ﬁgure 3. The maximum NPL statistic in thisbe involved in familial cancers (LeBeau and Rowley
interval of 10.13 corresponds to an exact P value of1984; Richards and Yu 1996). The observation of a
.00098 that the observed marker segregation would oc-fragile site on 16q22 in one small leukemia family (Ferro
cur under the null hypothesis of no linkage.et al. 1994) suggested that this region may contain a
locus for familial leukemia (Horwitz et al. 1996a; Hor-
Preliminary Mutational Analysiswitz 1997). Therefore, we evaluated the distamycin-sen-
sitive FRA16B site resulting from ampliﬁcation of an A possible explanation for the observation of antici-
pation in familial leukemia (Horwitz et al. 1996a) isAT-rich minisatellite sequence at the 16q21-22.1 bound-
ary (Yu et al. 1997). Pathological expansion of the mini- dynamic mutation of repetitive DNA sequences. The
E2F-4 transcription factor interacts with the RB homo-satellite to lengths productive of a fragile site was not
detected in individuals in two branches of the family logue p107 and is implicated in control of the cell cycle
(Ginsberg et al. 1994); it has been mapped to 16q22.1(ﬁg. 2). However, the ﬁnding that allele 5 is coinherited
Table 1
Pairwise LOD Scores between Familial Leukemia and Chromosomes 9p21-22 and 21q22.1-22.2
LOD SCORE AT u Å
Marker .001 .01 .05 .1 .2 .3 .4 Zmax umax
D9S126 01.67 0.69 0.08 .11 .20 .16 .09 .20 .21
IFNA 04.46 02.50 01.16 0.63 0.18 0.01 .04 .04 .40
UT7582 0 05.10 03.02 02.13 01.23 0.69 0.30 0 .5
D21S263 02.21 01.22 0.57 0.33 0.14 0.06 0.03 0 .5
IFNAR 04.43 02.46 01.14 0.64 0.23 0.07 0.01 0 .5
D21S65 05.20 03.20 01.83 01.26 0.71 0.40 0.18 0 .5
D21S167 04.57 02.61 01.28 0.77 0.34 0.15 0.06 0 .5
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expansions of repetitive DNA sequences (Schalling et al.
1993). There is no evidence for the presence of a large
CAG repeat in individuals in this family. Note, however,
that this does not completely exclude the possibility of
pathological expansion of a short CAG repeat below the
limit of RED detection, such as occurs in spinocerebellar
ataxia (SCA) type 6 (Zhuchenko et al. 1997).
Discussion
Of the three candidate loci for leukemia in this family
that we have proposed, we have excluded 9p21-22 and
21q22.1-22.2 by linkage analysis. We are unable to ex-
clude 16q21-23.2 and, in fact, ﬁnd evidence supporting
linkage to this region. The highest two-point LOD score
of 2.82 with D16S522 at u Å 0 is below the generally
accepted linkage criterion of a LOD score §3.0. Never-
theless, we believe that this result is important for the
following two reasons. First, linkage analysis here is
vulnerable to a loss of information frommissing individ-
uals, incompletely informative markers, and the possi-
bility of model misspeciﬁcation resulting from complex
Figure 2 PCR analysis of FRA16B minisatellite repeat. Allele inheritance (Horwitz 1997). To extract linkage informa-
numbering is relative to additional alleles that have been identiﬁed in tion maximally, we examined the genotype data using
a CEPH control population (not shown). nonparametric linkage analysis (Kruglyak et al. 1996).
NPL is a computationally tractable method based on
multipoint analysis of genotypic identity by descent. It
has the advantages of greater power to detect signiﬁcantand contains a polymorphic polyserine-encoding CAG
repeat (Ginsberg et al. 1994). All individuals in this fam- linkage with incomplete pedigree data and is indepen-
dent of inheritance model. The P value correspondingily appear to be homozygous for the most common allele
of 13 repeats (not shown), excluding expansion of this to the maximum NPL statistic is .00098. Notably, this
is less than the conditional probability of linkage of .001repeat as a cause of leukemia here.
Since this family displays apparent autosomal domi- deﬁned by the two-point LOD score standard of 3.0 and
is nearly equal to the conditional probability of linkagenant inheritance and, so far, all the repeat expansions
with dominant inheritance are CAG triplets (La Spada et (1003.01) corresponding to the theoretical maximum
LOD score of Ç3.01 that can be generated from thisal. 1994; Sutherland and Richards 1995), we conducted
RED analysis (ﬁg. 3) to determine whether this family pedigree structure of 11 meioses with missing individu-
als (as approximated from a two-point simulation studywas transmitting an expanded CAG repeat (anywhere
in the genome). The RED method is a general procedure with a fully informative marker and nearly inﬁnitely rare
and polymorphic alleles). Second, familial leukemia isbased on the ligase chain reaction for detecting large
Table 2
Pairwise LOD Scores between Familial Leukemia and Chromosome 16q21-23.2
LOD SCORE AT u Å
Marker 0 .01 .05 .1 .2 .3 .4 Zmax umax
D16S451 03.00 01.29 0.52 0.19 .06 .12 .08 .12 .30
D16S265 2.66 2.61 2.41 2.14 1.56 .94 .36 2.66 0
D16S186 .97 .96 .89 .79 .59 .38 .18 .97 0
D16S398 1.81 1.77 1.62 1.44 1.05 .66 .29 1.81 0
D16S301 .99 .98 .93 .86 .68 .48 .25 .99 0
D16S522 2.82 2.77 2.55 2.28 1.69 1.04 .41 2.82 0
D16S395 1.42 1.38 1.23 1.04 .68 .36 .13 1.42 0
D16S289 02.79 0.51 .09 .26 .31 .25 .14 .32 .18
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Figure 3 Nonparametric linkage analysis. Shown is the output of the GENEHUNTER program with NPL score (thick line) on the left
ordinate and the information content (thin line) on the right ordinate. The NPLmax occurs at a map position of 5.99 cM with a corresponding
P value of .00098. The indicated intermarker distances from the corresponding genetic maps (Shen et al. 1994; Kozman et al. 1995) were used
in the analysis.
exceedingly rare, and the families are generally small family (Gunz et al. 1978), HLA types differed among
affected individuals. Three siblings developing CLL hadand ascertained after most affected individuals have died
(Horwitz et al. 1996a; Horwitz 1997), limiting opportu- a constitutional deletion of the short arm of chromo-
some 22 (Fitzgerald and Hamer 1969). Two brothersnities for further sampling. Deﬁnitive linkage results may
not be obtainable in a single study. The identiﬁcation with childhood myelodysplasia with monosomy 7, a dis-
order that appears to be autosomal recessive (Horwitzof reasonable candidate regions will facilitate the study
of additional small families that are ascertained in the 1997), had constitutional inversion of chromosome
1p22q23 (Paul et al. 1987). And, as noted, a father-future.
There are clinical differences between some of the re- daughter pair with AML and ALL apparently coinher-
ited a 16q22 fragile site (Ferro et al. 1994).ported leukemia families (Horwitz 1997). The exclusion
of linkage to 21q22.1-22.2, a locus to which inherited We were led to test for instability of repetitive DNA
sequence tracts, because we had previously observed an-AML is mapped in another family (Ho et al. 1996),
demonstrates that familial leukemia is a genetically het- ticipation in the form of a declining intergenerational
age at onset in the inheritance of familial leukemia (Hor-erogeneous disease. Evidence for other loci for familial
leukemia is limited. Two brothers (Blattner et al. 1978) witz et al. 1996a). A preliminary mutational analysis
excludes minisatellite repeat ampliﬁcation at thewith acute lymphocytic leukemia (ALL) shared two
HLA haplotypes, and, in a different family (Kato et al. FRA16B fragile site and CAG trinucleotide repeat am-
pliﬁcation in the polyserine coding region of the E2F-41983), two ﬁrst cousins (whose parents were half sib-
lings of one another) with ALL shared a common HLA transcription factor as responsible for leukemia in this
family. Negative RED analysis further excludes largehaplotype, thereby suggesting the possibility of linkage
to chromosome 6p. However, in a family with multiple CAG repeat expansion as causative. Dynamic mutation
of repetitive sequence elements is the only documentedsiblings with chronic lymphocytic leukemia (CLL)
(Schweitzer et al. 1973) and a multigenerational AML molecular mechanism for anticipation in inherited neu-
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mice with targeted interruption of CBFB includes CNS
bleeding (Castilla et al. 1996; Wang et al. 1996); in
the presently studied family, three individuals in three
generations died of hemorrhagic stroke at young ages
(Horwitz et al. 1996b). It is interesting that a gene en-
coding another subunit of the hematopoietic CBF tran-
scriptional complex, CBFA, maps to the region on
21q22.1-22.2 (Speck and Stacy 1995), to which the
other family with AML predisposition has been linked
(Ho et al. 1996), although, thus far, there is no evidence
of mutation of CBFA in that family (Legare et al. 1995).
Moreover, the two known CBFA homologues, AML2
and AML3, map to 1p and 6p, respectively (Levanon et
al. 1994; Wijmenga et al. 1995), where, as discussed
above, there is suggestive support for localization of fa-
milial myelodysplasia and familial ALL. Third, SCA4
has been mapped to 16q22.1 (Flanigan et al. 1996). Like
the other spinocerebellar ataxias, SCA4 also demon-
strates anticipation (Flanigan et al. 1996). It is clinically
differentiated from the other types, however, by the ad-
ditional presence of an axonal neuropathy, and the diag-
nosis can be clinically confused with Friedreich ataxia
(Flanigan et al. 1996). Of note, the grandson of patient
II-3 carries the diagnosis of Friedreich ataxia (Horwitz
et al. 1996b), but the results of molecular genetic testing
for this disorder have not been available for conﬁrma-
tion. The possibility that this family may also transmit
SCA4, then, could be a signiﬁcant observation, espe-
cially in light of the overlap of spinocerebellar ataxia
and leukemia in yet another family (Li et al. 1981).
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